Synergy and antagonism of combinations with quinolones
- 1 April 1991
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 10 (4) , 255-261
- https://doi.org/10.1007/bf01966998
Abstract
Combinations of fluoroquinolones with other antimicrobial agents have been extensively investigated. Combinations of fluoroquinolones with aminoglycosides, beta-lactams, imidazoles, macrolides and clindamycin infrequently show synergy againstEnterobacteriaceae and gram-positive bacteria. These combinations rarely show antagonism. Combinations of rifampin with fluoroquinolones tested againstStaphylococcus aureus have been reported to show synergy and antagonism, and in vitro results have not correlated with results of animal infection experiments. AgainstPseudomonas aeruginosa combinations of antipseudomonas penicillins or imipenem with fluoroquinolones are synergistic for 20 % to 50 % of isolates in vitro and also are synergistic in animal models of infection, whereas combinations of aminoglycosides with fluoroquinolones rarely show synergy againstPseudomonas aeruginosa. Against anaerobic species such asBacteroides fragilis combinations of fluoroquinolones with clindamycin, anti-anaerobic penicillins, cephalosporins or imidazoles are occasionally synergistic but usually indifferent. Ciprofloxacin and ofloxacin combined with antituberculosis agents have activity againstMycobacterium tuberculosis and atypical mycobacteria. In general, fluoroquinolones should be combined with other agents not to achieve synergy, which is extremely variable, but to provide activity against bacteria inadequately inhibited by the fluoroquinolones.Keywords
This publication has 48 references indexed in Scilit:
- Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosisJournal of Antimicrobial Chemotherapy, 1988
- In vitro Antibacterial Activity of Imipenem in Combination with Newer Quinolone DerivativesChemotherapy, 1988
- Interactions between antibacterial agents of the quinolone group and nitrofurantoinJournal of Antimicrobial Chemotherapy, 1987
- Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental pseudomonas infections in neutropenic miceJournal of Antimicrobial Chemotherapy, 1987
- Synergy of Imipenem – A Novel Carbapenem, and Rifampin and Ciprofloxacin against Pseudomonasaeruginosa, Serratiamarcescens and Enterobacter SpeciesChemotherapy, 1987
- In-vitro study of the activity of ciprofloxacin combined with amikacin or ceftazidime against Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 1986
- Ciprofloxacin, azlocilin, ceftizoxime and amikacin alone and in combination against Gram-negative bacilli in an infected chamber modelJournal of Antimicrobial Chemotherapy, 1986
- The in-vitro activity of ciprofloxacin in combination with other agents against anaerobes of clinical interestJournal of Antimicrobial Chemotherapy, 1986
- Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains ofAcinetobacter anitratum in vitroEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985